Carlsmed, Inc.

NASDAQ: CARL · Healthcare · Medical - Devices

PublicHQ Carlsbad, CA · San DiegoCIK 0001794546Reports USD

#435 of 1,418 Healthcare companies by revenuetop-quartile growth

EA Score

54D

FH 63DQ 42GM —SS 47

v0.1 · 55/100 weight · provisional

↑ Altman-Z, filing timeliness · ↓ disclosure history, listing tenure

Methodology →

Revenue TTM

$63.3M

Rev growth YoY (TTM)

+65.4%

Net income (FY)

-$29.6M

Employees

127

as of 2026-08-13

Market cap

$373.0M

as of 2026-08-13

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$50.5M$50.5M2025

Net income-$29.6M-$29.6M2025

Operating income-$30.6M-$30.6M2025

Total assets$130.1M$130.1M2025

Liabilities$31.3M$31.3M2025

Equity$98.9M$98.9M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Carlsmed, Inc.’s revenue?

Carlsmed, Inc. booked $50.5M in FY2025 revenue, growing 86% year over year — faster than most Healthcare companies we track, at a -58.7% net margin.

Peers · Healthcare

Neptune Wellness Solutions Inc.——LENSAR Inc55C Cipher Pharmaceuticals Inc.84B+Minerva Surgical, Inc.——Charlotte's Web Holdings, Inc.44D Lexicon Pharmaceuticals, Inc.59C

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Realty Income Corporation$5.7B60C Sempra$12.4B64C DexCom, Inc.$4.7B87A ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+

Key facts

CEOMichael Cordonnier

SectorHealthcare

IndustryMedical - Devices

HeadquartersCarlsbad, CA

ExchangeNASDAQ: CARL

Employees127

IPO date2025-07-23

Latest filings

10-Q2026-08-05 8-K2026-08-05 8-K2026-06-03 8-K2026-05-05 10-Q2026-05-05 DEF 14A2026-04-22 8-K2026-02-25 10-K2026-02-25

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.